![Methanone,[6-methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-](https://static.cymitquimica.com/cas-image/393539-methanone-6-methoxy-2-4-methoxyphenyl-benzo-b-thien-3-yl-4-2-1-piperidinyl-ethoxy-phenyl.png)
CAS 84541-38-8: Methanone,[6-methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-
Formula:C30H31NO4S
- Synonyms:
- [6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Raloxifene Dimethoxy Impurity REF: 4Z-R-0112CAS: 84541-38-8 | - - - | To inquire | Mon 21 Apr 25 |
 | Raloxifene Bismethyl Ether REF: TM-T19544CAS: 84541-38-8 | 98% | To inquire | Mon 05 May 25 |
 | Raloxifene Bismethyl Ether REF: TR-R100010CAS: 84541-38-8 | - - - | 178.00 € | Tue 27 May 25 |
 | Raloxifene bismethyl ether REF: 3D-FR27667CAS: 84541-38-8 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-R-0112
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 21 Apr 2025
Raloxifene Bismethyl Ether
CAS:84541-38-8
Raloxifene Bismethyl Ether is a Raloxifene metabolite and an estrogen receptor inactive compound on which …
Formula:
C30H31NO4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
501.64
Ref: TM-T19544
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 5 May 2025
Raloxifene Bismethyl Ether
Controlled ProductCAS:84541-38-8
Applications An intermediate in the synthesis of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. References …
Formula:
C30H31NO4S
Color and Shape:
Neat
Molecular weight:
501.64
Ref: TR-R100010
| 5mg | 178.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Raloxifene bismethyl ether
CAS:84541-38-8
Raloxifene bismethyl ether is a deformation product of raloxifene that is used to treat osteoporosis. …
Formula:
C30H31NO4S
Purity:
Min. 95%
Molecular weight:
501.64 g/mol
Ref: 3D-FR27667
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
